Drugs / HT-2157
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01413932 | Jul 2011 → Dec 2012 | major depressive disorder | Dart NeuroScience, LLC | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HT-2157 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01413932 ↗ |
| Known as | SNAP-37889 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297765 ↗ |
| Route | Oral | “QD oral dosing” NCT01413932 ↗ |